In vitro and in vivo susceptibility of Borrelia burgdorferi.

V P Mursic, B Wilske, G Schierz, M Holmburger, E Süss
{"title":"In vitro and in vivo susceptibility of Borrelia burgdorferi.","authors":"V P Mursic,&nbsp;B Wilske,&nbsp;G Schierz,&nbsp;M Holmburger,&nbsp;E Süss","doi":"10.1007/BF02013102","DOIUrl":null,"url":null,"abstract":"<p><p>The antispirochetal activity in vitro and in vivo of several antibiotics against ten isolates of Borrelia burgdorferi from human spinal fluids and skin biopsies was determined. Borrelia burgdorferi was most susceptible in vitro to erythromycin, ceftriaxone and cefotaxime (MIC90: 0.06, 0.06, 0.12 mcg/ml respectively). Less activity was observed with tetracycline, amoxycillin and lincomycin (MIC90: 0.50 mcg/ml), imipenem and augmentin (MIC90: 0.25 mcg/ml), oxacillin (MIC90: 1 mcg/ml), ciprofloxacin (MIC90: 2 mcg/ml) and ofloxacin (MIC90: 4 mcg/ml). Penicillin G, normally regarded as appropriate treatment for Lyme disease, had an MIC90 of only 4 mcg/ml. With the exception of erythromycin, activity in vitro corresponded to the activity in vivo. Erythromycin, however, was less active in vivo, and penicillin G showed poor activity both in vitro and in vivo.</p>","PeriodicalId":11958,"journal":{"name":"European Journal of Clinical Microbiology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1987-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02013102","citationCount":"36","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF02013102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 36

Abstract

The antispirochetal activity in vitro and in vivo of several antibiotics against ten isolates of Borrelia burgdorferi from human spinal fluids and skin biopsies was determined. Borrelia burgdorferi was most susceptible in vitro to erythromycin, ceftriaxone and cefotaxime (MIC90: 0.06, 0.06, 0.12 mcg/ml respectively). Less activity was observed with tetracycline, amoxycillin and lincomycin (MIC90: 0.50 mcg/ml), imipenem and augmentin (MIC90: 0.25 mcg/ml), oxacillin (MIC90: 1 mcg/ml), ciprofloxacin (MIC90: 2 mcg/ml) and ofloxacin (MIC90: 4 mcg/ml). Penicillin G, normally regarded as appropriate treatment for Lyme disease, had an MIC90 of only 4 mcg/ml. With the exception of erythromycin, activity in vitro corresponded to the activity in vivo. Erythromycin, however, was less active in vivo, and penicillin G showed poor activity both in vitro and in vivo.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
伯氏疏螺旋体的体外和体内敏感性。
测定了几种抗生素对人体脊髓液和皮肤活检分离的10株伯氏疏螺旋体的体外和体内抗螺旋体活性。伯氏疏螺旋体对红霉素、头孢曲松和头孢噻肟最敏感(MIC90分别为0.06、0.06、0.12 mcg/ml)。四环素、阿莫西林和林可霉素(MIC90: 0.50 mcg/ml)、亚胺培南和增强素(MIC90: 0.25 mcg/ml)、唑西林(MIC90: 1 mcg/ml)、环丙沙星(MIC90: 2 mcg/ml)和氧氟沙星(MIC90: 4 mcg/ml)活性较低。青霉素G通常被认为是莱姆病的适当治疗方法,其MIC90仅为4微克/毫升。除红霉素外,体外活性与体内活性基本一致。红霉素的体内活性较低,青霉素G的体内和体外活性均较差。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Modulation of human neutrophil and monocyte oxidative burst by Legionella pneumophila sonic extract. Evaluation of three methods for typing herpes simplex virus. Comparative activity of LY146032 against anaerobic cocci. Comparative in vitro activity of the new peptolide antibiotic LY146032 against staphylococci. LY146032 treatment of Clostridium difficile colitis in hamsters.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1